BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28887018)

  • 1. DPP9 enzyme activity controls survival of mouse migratory tongue muscle progenitors and its absence leads to neonatal lethality due to suckling defect.
    Kim M; Minoux M; Piaia A; Kueng B; Gapp B; Weber D; Haller C; Barbieri S; Namoto K; Lorenz T; Wirsching J; Bassilana F; Dietrich W; Rijli FM; Ksiazek I
    Dev Biol; 2017 Nov; 431(2):297-308. PubMed ID: 28887018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DPP9 enzymatic activity in hematopoietic cells is dispensable for mouse hematopoiesis.
    Kim M; von Muenchow L; Le Meur T; Kueng B; Gapp B; Weber D; Dietrich W; Kovarik J; Rolink AG; Ksiazek I
    Immunol Lett; 2018 Jun; 198():60-65. PubMed ID: 29709545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted inactivation of dipeptidyl peptidase 9 enzymatic activity causes mouse neonate lethality.
    Gall MG; Chen Y; Vieira de Ribeiro AJ; Zhang H; Bailey CG; Spielman DS; Yu DM; Gorrell MD
    PLoS One; 2013; 8(11):e78378. PubMed ID: 24223149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipeptidyl peptidase 9 enzymatic activity influences the expression of neonatal metabolic genes.
    Chen Y; Gall MG; Zhang H; Keane FM; McCaughan GW; Yu DM; Gorrell MD
    Exp Cell Res; 2016 Mar; 342(1):72-82. PubMed ID: 26930324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune regeneration in irradiated mice is not impaired by the absence of DPP9 enzymatic activity.
    Gall MG; Zhang HE; Lee Q; Jolly CJ; McCaughan GW; Cook A; Roediger B; Gorrell MD
    Sci Rep; 2019 May; 9(1):7292. PubMed ID: 31086209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel dipeptidyl peptidase 9 substrates by two-dimensional differential in-gel electrophoresis.
    Zhang H; Maqsudi S; Rainczuk A; Duffield N; Lawrence J; Keane FM; Justa-Schuch D; Geiss-Friedlander R; Gorrell MD; Stephens AN
    FEBS J; 2015 Oct; 282(19):3737-57. PubMed ID: 26175140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl peptidase 9 (DPP9) in human skin cells.
    Gabrilovac J; Čupić B; Zapletal E; Kraus O; Jakić-Razumović J
    Immunobiology; 2017 Feb; 222(2):327-342. PubMed ID: 27682012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptidyl peptidase 9 subcellular localization and a role in cell adhesion involving focal adhesion kinase and paxillin.
    Zhang H; Chen Y; Wadham C; McCaughan GW; Keane FM; Gorrell MD
    Biochim Biophys Acta; 2015 Feb; 1853(2):470-80. PubMed ID: 25486458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in understanding the expression and function of dipeptidyl peptidase 8 and 9.
    Zhang H; Chen Y; Keane FM; Gorrell MD
    Mol Cancer Res; 2013 Dec; 11(12):1487-96. PubMed ID: 24038034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptidyl-peptidase 9 regulates the dynamics of tumorigenesis and metastasis in breast cancer.
    Heß L; Aliar K; Grünwald BT; Griffin R; Lozan A; Knöller M; Khokha R; Brummer T; Reinheckel T
    Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167133. PubMed ID: 38531482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, subcellular localisation, and possible roles of dipeptidyl peptidase 9 (DPP9) in murine macrophages.
    Zapletal E; Cupic B; Gabrilovac J
    Cell Biochem Funct; 2017 Mar; 35(2):124-137. PubMed ID: 28256001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel role of dipeptidyl peptidase 9 in epidermal growth factor signaling.
    Yao TW; Kim WS; Yu DM; Sharbeen G; McCaughan GW; Choi KY; Xia P; Gorrell MD
    Mol Cancer Res; 2011 Jul; 9(7):948-59. PubMed ID: 21622624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical properties and expression profile of human prolyl dipeptidase DPP9.
    Tang HK; Tang HY; Hsu SC; Chu YR; Chien CH; Shu CH; Chen X
    Arch Biochem Biophys; 2009 May; 485(2):120-7. PubMed ID: 19268648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DPP8 and DPP9 expression in cynomolgus monkey and Sprague Dawley rat tissues.
    Harstad EB; Rosenblum JS; Gorrell MD; Achanzar WE; Minimo L; Wu J; Rosini-Marthaler L; Gullo R; Ordway ND; Kirby MS; Chadwick KD; Cosma GN; Moyer CF
    Regul Pept; 2013 Sep; 186():26-35. PubMed ID: 23850796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of Islet1-expressing splanchnic mesoderm cells to distinct branchiomeric muscles reveals significant heterogeneity in head muscle development.
    Nathan E; Monovich A; Tirosh-Finkel L; Harrelson Z; Rousso T; Rinon A; Harel I; Evans SM; Tzahor E
    Development; 2008 Feb; 135(4):647-57. PubMed ID: 18184728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DPP9 deficiency: An inflammasomopathy that can be rescued by lowering NLRP1/IL-1 signaling.
    Harapas CR; Robinson KS; Lay K; Wong J; Moreno Traspas R; Nabavizadeh N; Rass-Rothschild A; Boisson B; Drutman SB; Laohamonthonkul P; Bonner D; Xiong JR; Gorrell MD; Davidson S; Yu CH; Fleming MD; Gudera J; Stein J; Ben-Harosh M; Groopman E; Shimamura A; Tamary H; Kayserili H; Hatipoğlu N; Casanova JL; Bernstein JA; Zhong FL; Masters SL; Reversade B
    Sci Immunol; 2022 Sep; 7(75):eabi4611. PubMed ID: 36112693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of upregulated dipeptidyl peptidase 9 (DPP9) in promoting tumoregenicity, metastasis and the prediction of poor prognosis in non-small cell lung cancer (NSCLC).
    Tang Z; Li J; Shen Q; Feng J; Liu H; Wang W; Xu L; Shi G; Ye X; Ge M; Zhou X; Ni S
    Int J Cancer; 2017 Apr; 140(7):1620-1632. PubMed ID: 27943262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SUMO1-E67 interacting loop peptide is an allosteric inhibitor of the dipeptidyl peptidases 8 and 9.
    Pilla E; Kilisch M; Lenz C; Urlaub H; Geiss-Friedlander R
    J Biol Chem; 2013 Nov; 288(45):32787-32796. PubMed ID: 24072711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dipeptidyl peptidase 9 (DPP9) from bovine testes: identification and characterization as the short form by mass spectrometry.
    Dubois V; Lambeir AM; Vandamme S; Matheeussen V; Guisez Y; Scharpé S; De Meester I
    Biochim Biophys Acta; 2010 Apr; 1804(4):781-8. PubMed ID: 20026260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytoplasmic peptidase DPP9 is rate-limiting for degradation of proline-containing peptides.
    Geiss-Friedlander R; Parmentier N; Möller U; Urlaub H; Van den Eynde BJ; Melchior F
    J Biol Chem; 2009 Oct; 284(40):27211-9. PubMed ID: 19667070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.